Skip to main content
Biocartis Group NV logo

Biocartis Group NV — Investor Relations & Filings

Ticker · BCART ISIN · BE0974281132 LEI · 549300J4HOJL5KG8HY54 BR Manufacturing
Open in API
Filings indexed 636 across all filing types
Latest filing 2017-04-11 AGM Information
Country BE Belgium
Listing BR BCART

About Biocartis Group NV

https://www.biocartis.com/en

Biocartis Group NV is a molecular diagnostics company that develops and commercializes its proprietary Idylla™ platform. This fully automated, sample-to-result system is designed to provide fast, easy, and actionable molecular diagnostic results, making advanced testing accessible to laboratories of any size. The company's primary focus is in the field of oncology, offering a menu of tests that support the diagnosis and treatment of various cancers, including lung, colorectal, melanoma, and breast cancer. Biocartis aims to enable personalized medicine for patients by providing universal access to molecular testing. The company also collaborates with pharmaceutical partners in the development of companion diagnostics.

Recent filings

Filing Released Lang Actions
PR AGM invitation NL FINAL.pdf
AGM Information Classification · 98% confidence The document is titled "Oproeping tot de gewone algemene aandeelhoudersvergadering" (Invitation to the Annual General Shareholders' Meeting) and explicitly invites shareholders to the meeting scheduled for May 12, 2017. This directly relates to the procedures and announcements surrounding the Annual General Meeting (AGM). Although it is a press release announcing the meeting, the core subject matter is the AGM itself, making 'AGM-R' the most specific classification, rather than a general 'RPA' or 'RNS'. The length (5481 chars) is substantial enough that it is not just a brief notification of publication, but the actual call/invitation document.
2017-04-11 Dutch
Biocartis Annual Report 2016_ENG_FINAL_web_unsigned.pdf
Annual Report Classification · 100% confidence The document is explicitly titled 'Annual report 2016' and contains comprehensive sections including business reviews, corporate governance, remuneration reports, consolidated financial statements, and auditor's reports. It covers the full fiscal year ending 31 December 2016. It meets all criteria for a standard Annual Report (10-K equivalent for non-US entities). FY 2016
2017-03-30 English
Biocartis Annual Report 2016_NL_FINAL_web_unsigned.pdf
Annual Report Classification · 100% confidence The document is explicitly titled 'Jaarverslag 2016' (Annual Report 2016) for Biocartis Group NV. It contains comprehensive sections including a management overview, corporate governance, remuneration report, consolidated financial statements, and an auditor's report. It covers the full fiscal year ending December 31, 2016, and provides detailed financial and operational analysis, fitting the definition of an Annual Report (10-K). FY 2016
2017-03-30 Dutch
170301 Press Release 2016FY Results ENG-FINAL.pdf
Earnings Release Classification · 98% confidence The document is explicitly titled 'PRESS RELEASE REGULATED - INSIDE INFORMATION' and announces 'BIOCARTIS ANNOUNCES 2016 RESULTS, 2017 OUTLOOK AND CHANGE IN CEO POSITION'. It details financial results for the full year 2016 (e.g., 'Total 2016 operating income amounted to EUR 13.8m') and provides guidance for 2017. This structure—a comprehensive summary of annual financial performance, operational highlights, and forward guidance—is characteristic of an Earnings Release (ER) or a preliminary announcement leading up to a full Annual Report (10-K). Since it is presented as a press release summarizing the results rather than the full, detailed statutory filing (10-K), and it covers the full fiscal year, the most appropriate classification is Earnings Release (ER). It is not a Call Transcript (CT) as it is a written release, nor is it a full Annual Report (10-K) which is a specific SEC filing format. The document length (68k chars) suggests it is substantial, but its format is that of an initial results announcement. FY 2016
2017-03-02 English
170301 Press Release 2016FY Results NL-FINAL.pdf
Earnings Release Classification · 98% confidence The document is titled 'PERSBERICHT GEREGLEMENTEERDE INFORMATIE' (Press Release Regulated Information) and announces the '2016 RESULTATEN, 2017 VOORUITZICHTEN EN VERANDERING IN CEO-POSITIE' (2016 Results, 2017 Outlook, and Change in CEO Position). It provides detailed financial highlights for the year 2016 (e.g., revenue, cash position) and operational updates, along with forward-looking statements for 2017. This structure—announcing period results and outlook—is characteristic of an Earnings Release (ER). Although it contains detailed financial data, the format is a press release announcing the results, not the comprehensive annual report (10-K) or the detailed interim report (IR). Furthermore, it mentions an accompanying webcast presentation to discuss the results, reinforcing its nature as an initial results announcement. It is not a 10-K because it is a press release format, not the full statutory filing. It is not an IR because it covers a full fiscal year (2016 results) and is presented as a press release summary, not a comprehensive quarterly/half-year report. It is not an MDA because while it contains management commentary, the primary focus is the quantitative financial results announcement. Therefore, the most appropriate classification is Earnings Release (ER). FY 2016
2017-03-02 Dutch
BIOCARTIS ANNOUNCES 2016 RESULTS, 2017 OUTLOOK AND CHANGE IN CEO POSITION
Earnings Release Classification · 98% confidence The document is explicitly titled 'PRESS RELEASE REGULATED - INSIDE INFORMATION' and announces 'BIOCARTIS ANNOUNCES 2016 RESULTS, 2017 OUTLOOK AND CHANGE IN CEO POSITION'. It details financial results for the full year 2016 (e.g., 'Total 2016 operating income amounted to EUR 13.8m') and provides guidance for 2017. This structure—a comprehensive summary of annual financial performance, operational highlights, and forward guidance—is characteristic of an Earnings Release (ER) or a preliminary announcement leading up to a full Annual Report (10-K). Since it is presented as a press release summarizing the results rather than the full, detailed statutory filing (10-K), and it covers the full fiscal year, the most appropriate classification is Earnings Release (ER). It is not a Call Transcript (CT) as it is a written release, nor is it a full Annual Report (10-K) which is a specific SEC filing format. The document length (68k chars) suggests it is substantial, but its format is that of an initial results announcement. FY 2016
2017-03-02 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.